Skip to content Norwegian Medical Products Agency Norwegian Medical Products Agency

Requests for Norway as RMS in the assessment of human medicinal products in the Decentralised Procedure – 2026

Published:

Changes

The Norwegian Medical Products Agency (NOMA) has no available slots for RMS in decentralised procedure (DCP); all positions for 2026 have now been allocated. Requests received after 5 March 2026 will not be considered by NOMA.

NOMA may make exceptions for medicinal products of significant importance to public health. This particularly applies to medicinal products announced in the list of needed products. In such cases, applicants are encouraged to contact NOMA.

From the fourth quarter of 2026, it will be possible to submit requests for RMS DCP slots for 2027. More information will be published on NOMA’s website.

This information does not apply to veterinary DCP applications.

See more news